The Impact of the German Tissue Act on the Manufacturing of Autologous and Allogeneic Stem Cell Preparations

Peter Schlenke,Karin Tapernon,C. Ahlke,Alexandra Mertens,Walter Sibrowski

The Impact of the German Tissue Act on the Manufacturing of Autologous and Allogeneic Stem Cell Preparations

2008

Peter Schlenke
Karin Tapernon
C. Ahlke
Alexandra Mertens
Walter Sibrowski

Cellular therapeutic agents considerably contribute to the optimal treatment of patients with hematological malignancies such as leukemia or nonhematological disorders. Over the last 50 years especial

Keywords:

Intensive care medicine
Bone marrow
Tissue engineering
Stem cell
Transplantation
Leukemia
Regenerative medicine
Medicine
Oncology
Pathology
optimal treatment
Internal medicine
Immunology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations